InvestorsHub Logo

Randy1111

10/29/20 1:10 PM

#17109 RE: StockHighAlert- #17108

Love all the past announcements and appreciate them but I really am looking more forward to whats been happening the last month and a half.
This needs a fresh injection of information such as sales and signed deals and financials. Waiting for that OTCQB designation.
Go Cytta

ProfitScout

11/02/20 12:40 PM

#17111 RE: StockHighAlert- #17108

The latest news from CYCA about its new agreement for US manufacturing of the company's advanced video streaming and related communications systems is coming at a very timely moment with so much pressure on emergency responders today. This is a very important development to help our emergency responce personnel do their jobs with the best possible equipment which they need now more than ever.

From the news:

Cytta Corp (OTCPINK: CYCA) Cytta announces an agreement that will enable us to achieve full scalability in our supply chain. The Company has finalized negotiations with a very well-respected US based manufacturer with the expertise, production capabilities and quality controls to enable Cytta to scale its IGAN Fusion and SUPR Stream production to meet rapidly growing demand.

Propelled by the success and customer satisfaction of our early SUPR and IGAN installations, Cytta is experiencing rapid growth in product demand. Rapid scalability in all aspects of our ongoing operations is mission critical. Achieving scale in manufacturing and maintaining inventory will support this growth and shorten the sales cycle.

Our chosen partner is well-recognized for its historically advanced engineering, design, and manufacture of complex electronic and electromechanical devices. Both IGAN Fusion and SUPR Stream will utilize their specific expertise with sophisticated printed circuit card assemblies, sub-assemblies, full product assemblies, and cable/wire harnesses. Our chosen manufacturer also has strong customer relationships with many of the world’s leading OEMs across complementary military and industrial markets.